NCT03935282 2026-04-15AH-HAWake Forest University Health SciencesPhase NA Completed645 enrolled 43 charts
NCT03213665 2026-04-13Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)National Cancer Institute (NCI)Phase 2 Completed20 enrolled 12 charts